文献速递心力衰竭与心肌病

FGF21-Sirtuin 3轴通过调控线粒体完整性介导运动对糖尿病心肌病的保护作用

FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity.
PubMed 文献 · Circulation · 2022-09-22

该研究探讨FGF21信号是否介导运动对糖尿病心肌病(DCM)的保护作用。通过多种基因敲除小鼠模型及人诱导多能干细胞来源心肌细胞,发现运动通过FGF21-AMPK/FOXO3/SIRT3轴保护线粒体完整性,该轴是DCM的潜在治疗靶点。

要点

  • 运动通过FGF21信号改善糖尿病心肌病心脏功能,该作用依赖肝源性FGF21和心肌β-klotho。
  • FGF21通过AMPK/FOXO3/SIRT3轴逆转糖尿病诱导的线粒体酶高乙酰化及功能障碍。
  • 恢复心脏SIRT3表达足以恢复FGF21敲除糖尿病小鼠对运动的反应性。

核心结论

  • FGF21-SIRT3轴通过维持线粒体完整性介导运动对糖尿病心肌病的保护作用,是潜在治疗靶点。

研究设计与样本

  • 研究采用全局或肝细胞特异性FGF21敲除小鼠、心肌细胞选择性β-klotho敲除小鼠及野生型同窝对照。
  • 小鼠经高脂饮食喂养和链脲佐菌素注射诱导DCM,随后进行6周运动干预并评估心脏功能。
  • 通过电镜、酶学检测及脂肪酸氧化和ATP生成评估心脏线粒体结构与功能。
  • 使用人诱导多能干细胞来源心肌细胞探究FGF21对抗毒性脂质诱导线粒体功能障碍的受体及受体后信号通路。

主要发现

  • 跑台运动显著诱导野生型小鼠心脏β-klotho表达,并显著减轻糖尿病诱导的心脏功能障碍,伴线粒体损伤减少和线粒体酶活性增加。
  • 全局或肝细胞选择性FGF21敲除、或心肌细胞特异性β-klotho敲除小鼠中,运动的上述心脏保护获益基本被消除。
  • 机制上,运动增强FGF21心脏作用,通过AMPK引起的FOXO3磷酸化诱导线粒体去乙酰化酶SIRT3表达,从而逆转糖尿病诱导的一组线粒体酶高乙酰化及功能损伤。
  • FGF21通过诱导AMPK/FOXO3/SIRT3信号轴,防止毒性脂质诱导的人诱导多能干细胞来源心肌细胞线粒体功能障碍和氧化应激。
  • 腺相关病毒介导恢复心脏SIRT3表达足以恢复糖尿病FGF21敲除小鼠对运动的反应性,改善线粒体功能障碍和DCM。

临床怎么用

  • 运动改善糖尿病心肌病的作用依赖完整的FGF21-β-klotho-AMPK/FOXO3/SIRT3信号轴。
  • FGF21-SIRT3轴可作为糖尿病心肌病的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Exercise is an effective nonpharmacological strategy to alleviate diabetic cardiomyopathy (DCM) through poorly defined mechanisms. FGF21 (fibroblast growth factor 21), a peptide hormone with pleiotropic benefits on cardiometabolic homeostasis, has been identified as an exercise responsive factor. This study aims to investigate whether FGF21 signaling mediates the benefits of exercise on DCM, and if so, to elucidate the underlying mechanisms. METHODS: The global or hepatocyte-specific FGF21 knockout mice, cardiomyocyte-selective β-klotho (the obligatory co-receptor for FGF21) knockout mice, and their wild-type littermates were subjected to high-fat diet feeding and injection of streptozotocin to induce DCM, followed by a 6-week exercise intervention and assessment of cardiac functions. Cardiac mitochondrial structure and function were assessed by electron microscopy, enzymatic assays, and measurements of fatty acid oxidation and ATP production. Human induced pluripotent stem cell-derived cardiomyocytes were used to investigate the receptor and postreceptor signaling pathways conferring the protective effects of FGF21 against toxic lipids-induced mitochondrial dysfunction. RESULTS: Treadmill exercise markedly induced cardiac expression of β-klotho and significantly attenuated diabetes-induced cardiac dysfunction in wild-type mice, accompanied by reduced mitochondrial damage and increased activities of mitochondrial enzymes in hearts. However, such cardioprotective benefits of exercise were largely abrogated in mice with global or hepatocyte-selective ablation of FGF21, or cardiomyocyte-specific deletion of β-klotho. Mechanistically, exercise enhanced the cardiac actions of FGF21 to induce the expression of the mitochondrial deacetylase SIRT3 by AMPK-evoked phosphorylation of FOXO3, thereby reversing diabetes-induced hyperacetylation and functional impairments of a cluster of mitochondrial enzymes. FGF21 prevented toxic lipids-induced mitochondrial dysfunction and oxidative stress by induction of the AMPK/FOXO3/SIRT3 signaling axis in human induced pluripotent stem cell-derived cardiomyocytes. Adeno-associated virus-mediated restoration of cardiac SIRT3 expression was sufficient to restore the responsiveness of diabetic FGF21 knockout mice to exercise in amelioration of mitochondrial dysfunction and DCM. CONCLUSIONS: The FGF21-SIRT3 axis mediates the protective effects of exercise against DCM by preserving mitochondrial integrity and represents a potential therapeutic target for DCM. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT03240978.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Jin L, Geng L, Ying L, et al. FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity. Circulation. 2022. PMID: 36134579. doi:10.1161/CIRCULATIONAHA.122.059631

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。